These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15262419)

  • 1. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
    Taylor SJ; McDonald JW; Sakiyama-Elbert SE
    J Control Release; 2004 Aug; 98(2):281-94. PubMed ID: 15262419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model.
    Taylor SJ; Sakiyama-Elbert SE
    J Control Release; 2006 Nov; 116(2):204-10. PubMed ID: 16919351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.
    Wood MD; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2008 Feb; 84(2):300-12. PubMed ID: 17607752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection.
    Tsai EC; Dalton PD; Shoichet MS; Tator CH
    Biomaterials; 2006 Jan; 27(3):519-33. PubMed ID: 16099035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system.
    Wood MD; Borschel GH; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2009 Jun; 89(4):909-18. PubMed ID: 18465825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury.
    Taylor SJ; Rosenzweig ES; McDonald JW; Sakiyama-Elbert SE
    J Control Release; 2006 Jul; 113(3):226-35. PubMed ID: 16797770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair.
    Liu T; Xu J; Chan BP; Chew SY
    J Biomed Mater Res A; 2012 Jan; 100(1):236-42. PubMed ID: 22042649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.
    Sakiyama-Elbert SE; Hubbell JA
    J Control Release; 2000 Oct; 69(1):149-58. PubMed ID: 11018553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.
    Willerth SM; Johnson PJ; Maxwell DJ; Parsons SR; Doukas ME; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2007 Jan; 80(1):13-23. PubMed ID: 16958043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
    Schense JC; Hubbell JA
    Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of fibrin derivatives for controlled release of heparin-binding growth factors.
    Sakiyama-Elbert SE; Hubbell JA
    J Control Release; 2000 Apr; 65(3):389-402. PubMed ID: 10699297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension.
    Schense JC; Bloch J; Aebischer P; Hubbell JA
    Nat Biotechnol; 2000 Apr; 18(4):415-9. PubMed ID: 10748522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of nerve growth factor from fibrin gel.
    Bhang SH; Jeon O; Choi CY; Kwon YH; Kim BS
    J Biomed Mater Res A; 2007 Mar; 80(4):998-1002. PubMed ID: 17117469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury.
    Johnson PJ; Parker SR; Sakiyama-Elbert SE
    Biotechnol Bioeng; 2009 Dec; 104(6):1207-14. PubMed ID: 19603426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering.
    Sakiyama SE; Schense JC; Hubbell JA
    FASEB J; 1999 Dec; 13(15):2214-24. PubMed ID: 10593869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury.
    Piantino J; Burdick JA; Goldberg D; Langer R; Benowitz LI
    Exp Neurol; 2006 Oct; 201(2):359-67. PubMed ID: 16764857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dorsal column sensory axons lack TrkC and are not rescued by local neurotrophin-3 infusions following spinal cord contusion in adult rats.
    Baker KA; Nakashima S; Hagg T
    Exp Neurol; 2007 May; 205(1):82-91. PubMed ID: 17316612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
    Stanwick JC; Baumann MD; Shoichet MS
    J Control Release; 2012 Jun; 160(3):666-75. PubMed ID: 22510446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury.
    Li G; Che MT; Zhang K; Qin LN; Zhang YT; Chen RQ; Rong LM; Liu S; Ding Y; Shen HY; Long SM; Wu JL; Ling EA; Zeng YS
    Biomaterials; 2016 Mar; 83():233-48. PubMed ID: 26774562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy.
    Kuo LT; Groves MJ; Scaravilli F; Sugden D; An SF
    Neuroscience; 2007 Jun; 147(2):491-507. PubMed ID: 17532148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.